SCHEMBL232856

SCHEMBL232856

CC=CC(=O)NCC(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.49
SMN1; SMN2 Q16637 3/20 0.45
POLB P06746 1/20 0.44
EGLN1 Q9GZT9 2/20 0.41
MAPT P10636 2/20 0.40
LMNA P02545 1/20 0.40
PTGS2 P35354 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
TGM2 P21980 1/20 0.40
KDM4E B2RXH2 1/20 0.40
CTH P32929 1/20 0.38
APEX1 P27695 1/20 0.36
ECE1 P42892 1/20 0.35
FAAH O00519 1/20 0.35
ITGB3 P05106 1/20 0.35
ITGB1 P05556 1/20 0.35
ITGAV P06756 1/20 0.35
ITGA5 P08648 1/20 0.35
PLA2G2A P14555 1/20 0.34
MME P08473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL232855 1.00 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2POLBEGLN1MAPT
SCHEMBL820926 0.85
SCHEMBL11100545 0.85
SCHEMBL820925 0.85
SCHEMBL9480613 0.85 CNR2 (0.50) ALDH1A1SMN1; SMN2POLBEGLN1MAPT
SCHEMBL23140079 0.81 TGM2 (0.40) ALDH1A1SMN1; SMN2POLBTGM2APEX1
SCHEMBL23140062 0.81 TGM2 (0.40) ALDH1A1SMN1; SMN2POLBTGM2APEX1
SCHEMBL2159350 0.80
SCHEMBL24703252 0.79 TGM2 (0.39) ALDH1A1SMN1; SMN2TGM2APEX1CNR2
SCHEMBL10810547 0.79 TGM2 (0.39) ALDH1A1SMN1; SMN2TGM2APEX1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022190030-A1 A TOPICAL FORMULATION FOR THE TREATMENT OF SKIN DISEASES AVACA PHARMA PRIVATE LIMITED (IN) 2022-09-15 WO claimed
CN-113156096-A Blood-based biomarkers for diagnosing coronary atherosclerotic disease 全球基因集团有限责任公司 2021-07-23 CN claimed
CN-106537145-B Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment 麦特博隆股份有限公司 2020-08-25 CN claimed
CN-110525075-A A kind of process of cigarette 3D raster print product HUBEI CHINA TOBACCO IND CO LTD 2019-12-03 CN claimed
CN-109384881-A A kind of method that cationic polymer preparation subtracts jelly 湖北工业大学 2019-02-26 CN claimed
CN-109134780-A A kind of hard and soft cabinet-type polycarboxylate water-reducer of main chain and preparation method 湖北工业大学 2019-01-04 CN claimed
CN-109053967-A A kind of stepwise hydrolysis release type polycarboxylic acid slump retaining agent and preparation method 湖北工业大学 2018-12-21 CN claimed
CN-109053966-A 2200 molecular weight polyether polycarboxylate water-reducers of one kind and preparation method 湖北工业大学 2018-12-21 CN claimed
CN-108911561-A 2200 molecular weight polyether polycarboxylic acid slump retaining agents of one kind and preparation method 湖北工业大学 2018-11-30 CN claimed
CN-108585594-A A kind of high and easy retentivity polycarboxylate water-reducer of 1800 molecular weight polyethers and preparation method 湖北工业大学 2018-09-28 CN claimed
WO-2011051813-A1 COMPOSITIONS AND METHODS FOR TREATING DERMATOLOGICAL CONDITIONS PAUL HARBHAJAN S (US) 2011-05-05 WO claimed
US-20110098229-A1 COMPOSITIONS AND METHODS FOR TREATING DERMATOLOGICAL CONDITIONS BIOMED RESEARCH & TECHNOLOGIES, INC. 2011-04-28 US claimed
EP-1098630-A2 COMPOSITION FOR ENHANCING EPIDERMAL LIPID PRODUCTION Biomed Research and Technologies, Inc. (US) 2001-05-16 EP claimed
US-6149924-A FOR TOPICAL APPLICATION BIOMED RESEARCH & TECHNOLOGIES, INC. (US) 2000-11-21 US claimed
WO-2000004870-A2 COMPOSITION FOR ENHANCING EPIDERMAL LIPID PRODUCTION BIOMED RESEARCH AND TECHNOLOGIES, INC. (US) 2000-02-03 WO claimed
US-5773522-A PRODRUGS FOR TREATMENT OF TUMORS PHARMACIA S.P.A. (IT) 1998-06-30 US claimed
US-5415864-A Colonic-targeted oral drug-dosage forms based on crosslinked hydrogels containing azobonds and exhibiting PH-dependent swelling UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 1995-05-16 US claimed
EP-0544671-A4 COLONIC-TARGETED ORAL DRUG-DOSAGE FORMS BASED ON CROSSLINKED HYDROGELS CONTAINING AZOBONDS AND EXHIBITING PH-DEPENDENT SWELLING 1993-09-15 EP claimed
EP-0544671-A1 COLONIC-TARGETED ORAL DRUG-DOSAGE FORMS BASED ON CROSSLINKED HYDROGELS CONTAINING AZOBONDS AND EXHIBITING pH-DEPENDENT SWELLING UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 1993-06-09 EP claimed
WO-1991016057-A1 COLONIC-TARGETED ORAL DRUG-DOSAGE FORMS BASED ON CROSSLINKED HYDROGELS CONTAINING AZOBONDS AND EXHIBITING pH-DEPENDENT SWELLING UNIVERSITY OF UTAH (US) 1991-10-31 WO claimed